Habitual Green Kiwifruit Consumption Is Associated with a Reduction in Upper Gastrointestinal Symptoms: A Systematic Scoping Review

被引:10
作者
Bayer, Simone B. [1 ]
Frampton, Chris M. [2 ]
Gearry, Richard B. [1 ]
Barbara, Giovanni [3 ,4 ]
机构
[1] Univ Otago Christchurch, Dept Med, Gastrointestinal Unit Translat Studies, Christchurch, New Zealand
[2] Univ Otago Christchurch, Biostat & Computat Biol Unit, Christchurch, New Zealand
[3] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[4] IRCCS Azienda Osped Univ, Bologna, Italy
关键词
reflux; dyspepsia; indigestion; abdominal pain; bloating; IRRITABLE-BOWEL-SYNDROME; DELICIOSA CV HAYWARD; FUNCTIONAL CONSTIPATION; CROSS-OVER; ACTINIDIN; PROTEINS; INCREASES; DIGESTION; TRIAL; SCALE;
D O I
10.1093/advances/nmac025
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Kiwifruit have known positive effects on digestion. During clinical intervention trials using kiwifruit to improve constipation, upper gastrointestinal (GI) symptoms such as abdominal discomfort and pain, indigestion, and reflux were also alleviated. We aimed to evaluate the evidence for upper GI symptom relief by kiwifruit in clinical trials on participants with functional constipation (FC), irritable bowel syndrome with constipation (IBS-C), and healthy participants, and to elucidate which symptoms may be relieved and whether a difference exists between the effects of gold and green kiwifruit. We executed a systematic scoping review of 3 electronic databases from 1947 through January 2021 to identify clinical trials that reported effects of green or gold kiwifruit or kiwifruit compounds on upper GI symptoms as secondary outcomes in healthy participants or participants with FC or IBS-C. Studies were divided into those using the Gastrointestinal Symptom Rating Scale (GSRS) and those using alternative measurement tools. GSRS outcomes were pooled and statistically analyzed; non-GSRS outcomes were summarized. We identified 12 clinical trials with a total of 661 participants (124 controls, 537 receiving intervention) providing evidence for symptom relief of upper GI symptoms by kiwifruit intake. Only 5 of the 12 clinical trials used the GSRS to assess upper GI symptom relief. We found good evidence that green kiwifruit may reduce abdominal discomfort and pain, and some evidence that kiwifruit consumption may attenuate indigestion. Pooled GSRS outcome analysis indicates an average reduction of -0.85 (95% CI: -1.1, -0.57; Z = 6.1) in abdominal pain scores and -0.33 (95% CI: -0.52, -0.15; Z = -3.5) in indigestion scores with habitual kiwifruit consumption. While the number of studies reporting on upper GI symptom relief with a comparable measurement is limited, there is consistent evidence for the efficacy of kiwifruit on upper GI symptom relief. More research to strengthen the evidence is recommended. Statement of Significance: This is the first review showing evidence that habitual consumption of kiwifruit may improve upper gastrointestinal symptoms such as abdominal pain and dyspepsia.
引用
收藏
页码:846 / 856
页数:11
相关论文
共 62 条
  • [1] Kiwifruit-derived supplements increase stool frequency in healthy adults: a randomized, double-blind, placebo-controlled study
    Ansell, Juliet
    Butts, Christine A.
    Paturi, Gunaranjan
    Eady, Sarah L.
    Wallace, Alison J.
    Hedderley, Duncan
    Gearry, Richard B.
    [J]. NUTRITION RESEARCH, 2015, 35 (05) : 401 - 408
  • [2] Ansell J, 2013, ADV FOOD NUTR RES, V68, P205, DOI 10.1016/B978-0-12-394294-4.00011-0
  • [3] How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors
    Aziz, Imran
    Tornblom, Hans
    Palsson, Olafur S.
    Whitehead, William E.
    Simren, Magnus
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (07) : 1017 - 1025
  • [4] Esophageal Disorders
    Aziz, Qasim
    Fass, Ronnie
    Gyawali, C. Prakash
    Miwa, Hiroto
    Pandolfino, John E.
    Zerbib, Frank
    [J]. GASTROENTEROLOGY, 2016, 150 (06) : 1368 - 1379
  • [5] Barbara G, 2018, GASTROENTEROLOGY, V154, pS979
  • [6] The Intestinal Microenvironment and Functional Gastrointestinal Disorders
    Barbara, Giovanni
    Feinle-Bisset, Christine
    Ghoshal, Uday C.
    Santos, Javier
    Vanner, Stepen J.
    Vergnolle, Nathalie
    Zoetendal, Erwin G.
    Quigley, Eamonn M.
    [J]. GASTROENTEROLOGY, 2016, 150 (06) : 1305 - +
  • [7] Bayer SB., 2021, INTERNAL REPORT CHRI
  • [8] Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function
    Bayer, Simone Birgit
    Gearry, Richard Blair
    Drummond, Lynley Ngaio
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2018, 58 (14) : 2432 - 2452
  • [9] Further Validation of the Visual Analogue Scale for Irritable Bowel Syndrome After Use in Clinical Practice
    Bengtsson, Mariette
    Persson, Jesper
    Sjolund, Kristina
    Ohlsson, Bodil
    [J]. GASTROENTEROLOGY NURSING, 2013, 36 (03) : 188 - 198
  • [10] Blatchford P, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.52